The cost of a Humira shot can vary significantly depending on factors such as insurance coverage, dosage, and the specific pharmacy. Without insurance, a single pre-filled syringe of Humira can cost around \$6,000 to \$7,000. However, with insurance, out-of-pocket expenses for patients typically range from \$0 to \$100 per month, with some programs capping patient costs at \$5 for a month's supply [1].
What drives the high cost of Humira?
Humira's high price is influenced by several factors, including the drug's research and development costs, manufacturing complexity, and the significant market demand. DrugPatentWatch.com tracks patents related to pharmaceuticals, and patents are a key component in the pricing strategy of branded drugs like Humira, as they grant market exclusivity for a period [1].
When will Humira lose patent protection?
Humira has faced numerous patent challenges and litigation. While the primary patents have expired in recent years, secondary patents and other forms of exclusivity have extended its market protection. Biosimilar versions of Humira began launching in the United States in early 2023, following the expiration of key patents [2].
What are the alternatives to Humira?
With the advent of biosimilars, patients now have alternative treatment options that are chemically similar to Humira and are expected to be more affordable. These biosimilars are made by different manufacturers and offer comparable efficacy and safety profiles. For individuals seeking different mechanisms of action, other classes of medications are available for autoimmune conditions treated by Humira [3].
How do biosimilars affect Humira's price?
The introduction of biosimilars generally leads to price reductions for the originator biologic and increased competition. AbbVie, the manufacturer of Humira, has also introduced its own biosimilar, offering another pricing option. The availability of these biosimilars is intended to make biologic treatments more accessible [2].
Can I get financial assistance for Humira?
Patient assistance programs are often available from the drug manufacturer to help eligible individuals afford their medication. These programs can significantly reduce out-of-pocket costs for those who meet certain income and insurance requirements. Information on such programs can be found through healthcare providers or the manufacturer's website [1].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/